Congo vs Sur: Previously treated cases tested for RR-/MDR-TB
Congo
100.0%
in 2024
Sur
62.0%
in 2024
Congo rank
1st
Sur rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Congo
- Sur
How they compare
Congo currently reports 100.0% against 62.0% in Sur, a difference of 38.0%.
That makes Congo's figure about 1.6 times Sur's.
The two have swapped places 7 times across 11 shared years of data; in 2013 it was Sur ahead.
Congo ranks 1st and Sur ranks 1st of 180 countries.
Across the 2 decades both report, Congo averaged higher in 1 and Sur in 1.
Head to head by decade
| Decade | Congo | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 77.2% | 64.2% | 13.0% | Congo |
| 2020s | 69.8% | 78.4% | 8.6% | Sur |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Congo or Sur?
- Congo, at 100.0% against 62.0% in Sur as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Congo and Sur?
- 38.0%, with Congo ahead.
- How many years of comparable data are there for Congo and Sur?
- 11 years are reported by both, from 2013 to 2024.
- How do Congo and Sur rank globally for previously treated cases tested for rr-/mdr-tb?
- Congo ranks 1st and Sur ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.